Ivana Magovcevic-Liebisch's Net Worth
$1.1 Million
Who is Ivana Magovcevic-Liebisch?
Ivana Magovcevic-Liebisch has an estimated net worth of $1.1 Million. This is based on reported shares across multiple companies, which include Vigil Neuroscience, Inc., Absci Corp, Aeglea BioTherapeutics, Inc., APPLIED GENETIC TECHNOLOGIES CORP, and DYAX CORP.
SEC CIK
Ivana Magovcevic-Liebisch's CIK is 0001279281
Past Insider Trading and Trends
2012 was Ivana Magovcevic-Liebisch's most active year for acquiring shares with 15 total transactions. Ivana Magovcevic-Liebisch's most active month to acquire stocks was the month of May. 2013 was Ivana Magovcevic-Liebisch's most active year for disposing of shares, totalling 17 transactions. Ivana Magovcevic-Liebisch's most active month to dispose stocks was the month of February. 2013 saw Ivana Magovcevic-Liebisch paying a total of $452,627.40 for 1,410,969 shares, this is the most they've acquired in one year. In 2013 Ivana Magovcevic-Liebisch cashed out on 1,395,343 shares for a total of $874,475.21, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vigil Neuroscience, Inc. (VIGL) Snapshot price: $2.86
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +1.96% | 4K |
$3.75 | $15,000.00 | 207.69K |
Nov 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +2.52% | 5K |
$3.68 | $18,379.00 | 203.69K |
May 2 - May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Absci Corp (ABSI) Snapshot price: $4.34
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aeglea BioTherapeutics, Inc. (AGLE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
APPLIED GENETIC TECHNOLOGIES CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
∞
| 3K |
$9.63 | $28,875.00 | 3K |
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DYAX CORP No price found
EVP; Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 4
| -16.21% | -7.86K |
$3.09 | -$408,838.81 | 40.63K |
Scheduled
|
Mar 6
| ||
Form 4
| -7.65% | -4.01K |
$3.24 | -$13,009.00 | 48.48K |
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +950.00% | 47.5K |
—
|
—
| 52.5K |
Feb 24
| |||
Form 4
|
∞
| 5K |
$1.50 | $7,500.00 | 5K |
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
$1.92 | -$13,806.83 |
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
$2.03 | -$16,936.15 |
0
|
May 26
| |||
Form 4
| -100.00% | -3.54K |
$3.10 | -$10,964.73 |
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 4
| -62.91% | -6.00K |
$5.00 | -$30,000.00 | 3.54K |
Scheduled
|
Apr 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
∞
| 16.41K |
$2.43 | $39,853.60 | 16.41K |
May 13
| |||
Form 4
|
—
|
0
|
$8.10 | -$117,949.36 |
0
|
Apr 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||